Cyclophosphamide in the nephrotic syndrome of childhood: its use in two groups of patients defined by clinical, light microscopic and immunopathologic findings.
D000505:Alopecia / Q000139:chemically induced; D001706:Biopsy; D001772:Blood Cell Count; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009404:Nephrotic Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D011507:Proteinuria / Q000188:drug therapy; D013256:Steroids / Q000627:therapeutic use
D013256:Steroids; D003520:Cyclophosphamide; D011241:Prednisone